Stratos Wealth Partners’s Strata Critical Medical Inc SRTA Stock Holding History

Stratos Wealth Partners’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-112,800	Closed	-$455K	–	1552
2025 Q2	$455K	Buy	112,800 +34,800	+45%	+$113K	0.01%	961
2025 Q1	$213K	Sell	78,000 -80	-0.1%	-$287	﹤0.01%	1248
2024 Q4	$332K	Buy	78,080 +41,720	+115%	+$159K	﹤0.01%	1108
2024 Q3	$107K	Sell	36,360 -17,720	-33%	-$56.4K	﹤0.01%	1389
2024 Q2	$188K	Buy	54,080 +23,375	+76%	+$78K	﹤0.01%	1276
2024 Q1	$87.5K	Buy	+30,705	New	+$94.7K	﹤0.01%	1341

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stratos Wealth Partners's SRTA Position: Q3 2025 in Review

Stratos Wealth Partners sold out of Strata Critical Medical Inc (SRTA) in Q3 2025, closing a stake of 112,800 shares — an estimated $455K sold.

Stratos Wealth Partners first reported a position in SRTA in Q1 2024 and held it in 6 quarters. The position peaked at $455K in Q2 2025. 137 funds tracked by Wall St. Rank hold SRTA as of Q3 2025.

Stratos Wealth Partners reported no remaining Strata Critical Medical Inc position as of Q3 2025 after selling out during the quarter.
Stratos Wealth Partners sold 112,800 Strata Critical Medical Inc shares in Q3 2025, an estimated $455K.
Stratos Wealth Partners first reported a position in Strata Critical Medical Inc in Q1 2024 and held it in 6 quarters.
Stratos Wealth Partners's Strata Critical Medical Inc position peaked at $455K in Q2 2025.
137 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q3 2025.

Based on Stratos Wealth Partners's 13F filing for Q3 2025, filed 6 Nov 2025.